SYNLOGIC, INC. Accrued Liabilities, Current
SYNLOGIC, INC. (SYBX) had Accrued Liabilities, Current of $1.04 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Accrued Liabilities, Current $1.04M.
- 2026-03-31: Accrued Liabilities, Current $1.16M.
- 2025-12-31: Accrued Liabilities, Current $915.00K.
- 2025-09-30: Accrued Liabilities, Current $858.00K.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.04M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $1.16M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $915.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $858.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $952.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $946.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $2.04M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $1.76M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.30M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $3.12M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $3.00M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $3.68M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.54M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $3.00M 10-Q · filed 2024-05-14 | $2.42M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $5.29M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $4.77M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $3.25M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.67M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $4.40M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $3.98M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $3.62M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $2.80M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $3.77M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $2.89M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.43M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $2.33M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $3.95M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $4.03M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $3.69M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $3.88M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $4.99M 10-K · filed 2020-03-12 | $5.03M 10-K · filed 2019-03-12 |
| 2018-09-30 | $4.49M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $6.55M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $4.24M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $4.82M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $5.52M 10-Q · filed 2017-11-13 | |
| 2016-12-31 | $2.30M 10-K · filed 2018-03-20 | |
| 2015-09-30 | $2.75M 10-Q · filed 2015-11-13 | |
| 2014-12-31 | $1.63M 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |